Nanexa recruits head of pharmaceutical development

15 March, 2021
- Regulatory

Nanexa today announces that the company has recruited Jonas Fransson as head of pharmaceutical development as part of a strengthening of the organization. Jonas Fransson has long and solid experience in drug development and will start on May 1 this year and will be part of Nanexa's management team.

"I am very glad to welcome Jonas to Nanexa. I have had the pleasure of working with him for some time at Pharmacia Upjohn and know that he will contribute to our development and business in a very good way. He is joining the team to increase our competence and experience in drug development, which will contribute both in the internal work and in our external contacts," said David Westberg, CEO of Nanexa.

Jonas Fransson has a PhD in pharmacy from Uppsala University and brings with him extensive knowledge and experience in drug development from his long career in the industry. He most recently had the role of Director Biopharmaceutical Drug Product Development at SOBI, where he has been since 2006. Prior to that, Jonas Fransson held a number of leading roles within the development organization at Pharmacia & Upjohn and Pfizer since 1998. He is the author and co-author of a number of scientific articles and is behind a number of patents in the field. Jonas Fransson is also a reputable speaker in the field of drug development and has participated in several international scientific conferences.